Chun-Lei Li Selected Research

Sublingual Administration

1/2003	Impaired endothelial function in the brachial artery after Kawasaki disease and the effects of intravenous administration of vitamin C.
9/2002	Angiotensin receptor antagonist losartan improves endothelial function of epicardial coronary arteries in patients with essential hypertension.
4/2002	Effects of the angiotensin receptor antagonist losartan on the response of the left main coronary artery to cold pressor test in patients with essential hypertension as assessed by echocardiography.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chun-Lei Li Research Topics

Disease

3	Neoplasms (Cancer) 01/2022 - 09/2005
2	Liver Neoplasms (Liver Cancer) 01/2022 - 09/2005
2	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 09/2005
2	Inflammation (Inflammations) 01/2022 - 04/2011
2	Newborn Respiratory Distress Syndrome 11/2020 - 01/2012
2	Hyperemia 01/2003 - 10/2002
2	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2003 - 10/2002
2	Essential Hypertension 09/2002 - 04/2002
1	Oral Lichen Planus 01/2022
1	Invasive Fungal Infections 11/2021
1	Infections 11/2021
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2021
1	Bacterial Infections (Bacterial Infection) 09/2021
1	Hypoxia (Hypoxemia) 03/2018
1	Pemphigus (Pemphigus Vulgaris) 01/2017
1	Heart Failure 01/2016
1	Pain (Aches) 01/2016
1	Ulcer 01/2016
1	Reperfusion Injury 01/2016
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2016
1	Brain Ischemia (Cerebral Ischemia) 01/2016
1	Ischemia 01/2016
1	Aphthous Stomatitis (Aphthous Ulcer) 01/2016
1	Sialadenitis 04/2011
1	Hypertension (High Blood Pressure) 04/2002

Drug/Important Bio-Agent (IBA)

4	Nitroglycerin (Dynamite)FDA LinkGeneric 01/2003 - 04/2002
2	CytokinesIBA 01/2022 - 04/2011
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 01/2003 - 10/2002
2	gamma-Globulins (gamma-Globulin)IBA 01/2003 - 10/2002
2	Angiotensin II Type 1 Receptor BlockersIBA 09/2002 - 04/2002
2	Angiotensin Receptor AntagonistsIBA 09/2002 - 04/2002
2	Losartan (Cozaar)FDA LinkGeneric 09/2002 - 04/2002
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	huachansuIBA 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	ChemokinesIBA 01/2022
1	Amphotericin B (Amphotericin)FDA LinkGeneric 11/2021
1	LipopolysaccharidesIBA 09/2021
1	Peptide Hydrolases (Proteases)FDA Link 09/2021
1	SmokeIBA 09/2021
1	GlucocorticoidsIBA 01/2017
1	Plant ExtractsIBA 01/2016
1	Propofol (Diprivan)FDA LinkGeneric 01/2016
1	salicylhydroxamic acid (SHAM)IBA 01/2016
1	Apoptosis Inducing FactorIBA 01/2016
1	Pulmonary Surfactant-Associated Protein BIBA 01/2012
1	GlucosidesIBA 04/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2005
1	Proteins (Proteins, Gene)FDA Link 09/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2005
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2005
1	Bromocriptine (Parlodel)FDA LinkGeneric 09/2005
1	Pharmaceutical PreparationsIBA 09/2005

Therapy/Procedure

3	Sublingual Administration 01/2003 - 04/2002
2	Intravenous Infusions 01/2003 - 10/2002
2	Intravenous Administration 01/2003 - 10/2002
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2021
1	Adjuvant Chemoradiotherapy 02/2021
1	Cannula 11/2020
1	Nutritional Support (Artificial Feeding) 03/2018
1	Therapeutics 01/2016
1	Defibrillators (Defibrillator) 01/2016
1	Cardiac Resynchronization Therapy 01/2016
1	Drug Therapy (Chemotherapy) 09/2005